PRRT2 and infection: Supporting this hypothesis, pharmacological inhibition of ERK1/2 (Manjunatha et al., 2017) and PKC (Lama et al., 2019) reduced RV replication in the brain in a mouse model of infection, although the pleiotropic actions of ERK1/2 make it difficult to determine whether this is an effect on FAT or another cellular process.